Search Results - "Ge, Shili"
-
1
T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals
Published in Cellular & molecular immunology (01-11-2021)Get full text
Journal Article -
2
Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin
Published in Clinical journal of the American Society of Nephrology (01-12-2011)“…Rituximab and intravenous Ig (IVIG) are commonly used for desensitization of HLA and blood group-incompatible (ABOi) transplants. However, serious infections…”
Get full text
Journal Article -
3
Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients
Published in Journal of immunology research (01-01-2017)“…Viral infections represent significant morbidity and mortality factors in kidney transplant recipients, with CMV, EBV, and BKV infections being most common…”
Get full text
Journal Article -
4
A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients
Published in Transplantation (01-11-2015)“…BACKGROUNDCurrent desensitization (DES) methods are not always effective. Thus, novel, more effective approaches are desirable. Interleukin (IL)-6 is an…”
Get full text
Journal Article -
5
Regulation of Anti-HLA Antibody-Dependent Natural Killer Cell Activation by Immunosuppressive Agents
Published in Transplantation (15-02-2014)Get full text
Journal Article -
6
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro
Published in Transplantation (01-08-2020)“…BACKGROUND:Antibody-dependent cell-mediated cytotoxicity (ADCC) is an important pathway responsible for antibody-mediated rejection (AMR). Imlifidase (IdeS)…”
Get full text
Journal Article -
7
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
Published in Clinical infectious diseases (15-12-2020)“…Abstract Background Preliminary data from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia patients indicate that a cytokine storm may…”
Get full text
Journal Article -
8
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
Published in The New England journal of medicine (03-08-2017)“…In this study, an IgG-degrading enzyme derived from Streptococcus pyogenes (IdeS) that cleaves human IgG into F(ab′) 2 and Fc fragments reduced or eliminated…”
Get full text
Journal Article -
9
Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients
Published in Transplantation (15-08-2014)“…BACKGROUNDHighly HLA-sensitized (HS) patients have difficulty accessing compatible donors, especially deceased donor (DD) transplants. Desensitization…”
Get full text
Journal Article -
10
Ontogeny of expression of transforming growth factor-β and its receptors and their possible relationship with scarless healing in human fetal skin
Published in Wound repair and regeneration (01-01-2005)“…Fetal cutaneous wounds that occur in early gestation heal without scar formation. Although much work has been done to characterize the role of transforming…”
Get full text
Journal Article -
11
Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated Rejection
Published in Transplantation (01-10-2017)“…BACKGROUNDSensitization to HLA remains a significant immunologic barrier to successful transplantation. Identifying immune mechanisms responsible for…”
Get full text
Journal Article -
12
Clazakizumab for desensitization in highly sensitized patients awaiting transplantation
Published in American journal of transplantation (01-04-2022)“…Alloantibodies are a significant barrier to successful transplantation. While desensitization has emerged, efficacy is limited. Interleukin‐6 (IL‐6) is an…”
Get full text
Journal Article -
13
CLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962)
Published in Transplantation (01-09-2020)Get full text
Journal Article -
14
CLAZAKIZUMAB (ANTI-IL-6) INDUCES FOXP3+ TREGS IN HIGHLY HLA SENSITIZED PATIENTS RECEIVING HLAI KIDNEY TRANSPLANTATION (NCT03380962)
Published in Transplantation (01-09-2020)Get full text
Journal Article -
15
Viral‐specific cytotoxic T‐cell responses in HLA‐sensitized kidney transplant patients maintained on everolimus and low‐dose tacrolimus
Published in Transplant infectious disease (01-04-2022)“…Background Maintenance with “everolimus + reduced dose tacrolimus” (Ev + Taclow) was reported to reduce the risk of viral infections compared to “tacrolimus +…”
Get full text
Journal Article -
16
-
17
Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts
Published in Kidney international reports (01-04-2022)“…Interleukin-6 (IL-6) is an important mediator of inflammation and activation of T cells, B cells, and plasma cells. Excessive IL-6 production is linked to…”
Get full text
Journal Article -
18
Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant Patients
Published in Transplantation (01-07-2017)“…BACKGROUNDDesensitization with IVIG + rituximab combined with alemtuzumab induction gives HLA-sensitized patients an opportunity for successful kidney…”
Get full text
Journal Article -
19
Regulation of Anti-HLA Antibody-Dependent Natural Killer Cell Activation by Immunosuppressive Agents
Published in Transplantation (15-02-2014)“…BACKGROUNDIt was demonstrated that human natural killer (NK) cells, via antibody-dependent cellular cytotoxicity (ADCC)-like mechanism, increase IFNγ…”
Get full text
Journal Article -
20
Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejection
Published in Transplant immunology (01-01-2015)“…Abstract Introduction Antibody-mediated rejection (ABMR) is dependent on complement activating donor-specific anti-HLA antibodies (DSA). This is commonly…”
Get full text
Journal Article